ArticleFrontiers in pharmacology2024

Case report: EGFR-TKI rechallenge after osimertinib-induced interstitial lung disease: a case report and literature review.

Xiaofei Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.